Laboratorios Farmaceuticos Rovi, S.A. Stock Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.25 EUR | -0.09% |
|
+0.17% | -7.98% |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
| Market Cap | 2.97B 3.4B 2.74B 2.57B 4.81B 321B 4.85B 32.61B 12.63B 158B 12.77B 12.49B 549B | P/E 2026 * |
22.2x | P/E 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.94B 3.38B 2.72B 2.55B 4.78B 319B 4.81B 32.36B 12.53B 157B 12.67B 12.4B 545B | EV / Sales 2026 * |
3.8x | EV / Sales 2027 * | 3.15x |
| Free-Float |
31.63% | Yield 2026 * |
1.68% | Yield 2027 * | 2.02% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -0.09% | ||
| 1 week | +0.17% | ||
| Current month | -2.18% | ||
| 1 month | -0.34% | ||
| 3 months | -27.50% | ||
| 6 months | -5.44% | ||
| Current year | -7.98% |
| 1 week | 58.1 |  | 59.3 |
| 1 month | 57.4 | | 61 |
| Current year | 57.4 | | 86.6 |
| 1 year | 51.85 | | 86.6 |
| 3 years | 38.38 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2007-07-26 | |
| Director of Finance/CFO | - | 2000-12-31 | |
| Chief Tech/Sci/R&D Officer | - | 2013-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2021-07-16 | |
| Director/Board Member | - | 2007-07-26 | |
| Director/Board Member | - | 2007-07-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | +0.17% | - | - | 3.42B | |
| -1.21% | -5.37% | +39.94% | +145.38% | 980B | |
| -2.48% | -4.17% | +51.52% | +39.07% | 550B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 382B | |
| -1.18% | +0.25% | +25.86% | +16.53% | 317B | |
| +0.61% | -2.53% | +25.46% | +12.27% | 270B | |
| +0.22% | -2.67% | +24.57% | +30.34% | 269B | |
| +4.59% | +3.68% | -39.28% | -46.92% | 191B | |
| -1.19% | -4.65% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 154B | |
| Average | -0.42% | -2.68% | +19.55% | +39.64% | 366B | |
| Weighted average by Cap. | -0.93% | -3.38% | +28.32% | +63.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 774M 888M 716M 671M 1.26B 83.74B 1.27B 8.51B 3.29B 41.22B 3.33B 3.26B 143B | 913M 1.05B 845M 791M 1.48B 98.79B 1.49B 10.04B 3.89B 48.62B 3.93B 3.85B 169B |
| Net income | 133M 153M 123M 115M 216M 14.39B 217M 1.46B 566M 7.08B 572M 560M 24.6B | 183M 209M 169M 158M 296M 19.75B 298M 2.01B 777M 9.72B 786M 769M 33.78B |
| Net Debt | -22.53M -25.84M -20.85M -19.53M -36.56M -2.44B -36.84M -248M -95.9M -1.2B -96.99M -94.9M -4.17B | -90.52M -104M -83.75M -78.45M -147M -9.79B -148M -995M -385M -4.82B -390M -381M -16.75B |
| Date | Price | Change |
|---|---|---|
| 26-06-19 | 58.25 € | -0.09% |
| 26-06-18 | 58.30 € | -0.77% |
| 26-06-17 | 58.75 € | +0.60% |
| 26-06-16 | 58.40 € | -0.17% |
| 26-06-15 | 58.50 € | -0.09% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
